Levodopa (Oral Inhalation) and Tofacitinib Extended-Release Tablets
Determining the interaction of Levodopa (Oral Inhalation) and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: levodopa
Brand name: Inbrija, Dopar, Larodopa
Synonyms: Levodopa inhalation
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Levodopa (Oral Inhalation)-Tofacitinib Tablets
- Levodopa (Oral Inhalation)-Tofranil
- Levodopa (Oral Inhalation)-Tofranil injection
- Levodopa (Oral Inhalation)-Tofranil-PM
- Levodopa (Oral Inhalation)-Tol-Tab
- Levodopa (Oral Inhalation)-Tolazamide
- Tofacitinib Extended-Release Tablets-Levodopa inhalation
- Tofacitinib Extended-Release Tablets-Levodopa, Carbidopa, and Entacapone
- Tofacitinib Extended-Release Tablets-Levodopa/Carbidopa
- Tofacitinib Extended-Release Tablets-Levofloxacin
- Tofacitinib Extended-Release Tablets-Levofloxacin (Systemic)
- Tofacitinib Extended-Release Tablets-Levofloxacin injection